Medical/Pharmaceuticals

Ozelle to Debut O-Cyte 1 at ADLM 2026, Bringing Speed to AI-Powered Morphology Intelligence

The upcoming global debut is set to mark a step forward in AI-powered hematology, advancing the 4th Generation of Hematology Analysis ANAHEIM, Calif. and FRANKFURT, Germany, June 30, 2026 /PRNewswire/ -- Ozelle will unveil O-Cyte 1, its newest automated hematology ana...

2026-06-30 03:00 3214

TrilliumBiO and The LAM Foundation Partner to Advance LAM Awareness and Education

Efforts include support for earlier diagnosis through LAMair™, TrilliumBiO's newly developed VEGF‑D test ROCKVILLE, Md. and CINCINNATI, June 29, 2026 /PRNewswire/ -- TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a commitment to raising awareness of lymph...

2026-06-29 22:15 2152

Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board

Deepening Its Commitment to Kidney Disease and Accelerating Toward Becoming a Global Leader in Renal Innovation SHANGHAI, June 29, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a biopharmaceutical company focused on kidney dise...

2026-06-29 20:00 6084

MALAYSIA HEALTHCARE CONNECTS CAMBODIAN FAMILIES WITH LEADING MALAYSIAN HOSPITALS DURING FIRST-EVER PHNOM PENH EXPO

PHNOM PENH, Cambodia, June 29, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) today launched the first-ever Malaysia Healthcare Expo (MHX) Phnom Penh, marking the first MHX to be held in Cambodia and the organisation's first consumer-focused healthcare expo outside Indonesia. Camb...

2026-06-29 12:56 2420

Remplir™: Australian Nerve Repair Device Supports Victims of War in Ukraine

PERTH, Australia, June 29, 2026 /PRNewswire/ -- Perth-based regenerative medicine company, Orthocell Ltd

2026-06-29 11:52 1360

International Health Innovation & Exchange Association (IHIEA) Launches in Hong Kong and Unveils Six-Point Action Blueprint

Focusing on cross-border healthcare, continuing medical education, innovation translation, Global Medical Excellence Center certification, data collaboration and standards for emerging technologies HONG KONG, June 29, 2026 /PRNewswire/ -- The International Health Innovation & Exchange Assoc...

2026-06-29 11:38 1359

4DMedical Receives TGA Approval for CT:VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia

Non-contrast, ventilation-perfusion imaging—from routine chest CT scans MELBOURNE, Australia, June 29, 2026 /PRNewswire/ -- 4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory imaging, today announced that CT:VQ™ technology has Therapeutic Goods Administration (TGA) approval a...

2026-06-29 11:04 1911

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026. Hearing loss is widely recog...

2026-06-27 06:01 3762

Frost & Sullivan Institute Honors Organizations Driving Transformative Impact Through Visionary Leadership

SILICON VALLEY, Calif., June 27, 2026 /PRNewswire/ -- The Frost & Sullivan Institute is proud to announce the recipients of the 2026 Visionary Growth Leadership Best Practices Recognition, honoring organizations that are setting new benchmarks for business leadership by tackling some of the world...

2026-06-27 02:30 3868

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

* Recommendation follows an Article 20 non-pharmacovigilance procedure  * Patients currently on TAVNEOS treatment should consult their treating physician   ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the...

2026-06-26 21:06 4859

Beyond Injections: S-CELL Unveils Breakthrough "Endogenous GLP-1" Formula Powered by Akkermansia P9 Signaling and CoreBiome® Technology

HONG KONG, June 26, 2026 /PRNewswire/ -- S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebiotic and Probiotic) supplement. This pioneering formula represents a paradigm shift in weight manageme...

2026-06-26 14:42 5786

Everest Medicines Announces China NMPA Acceptance of the Biologics License Application for LEROCHOL® in Adults with Hypercholesterolemia

SHANGHAI, June 26, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that China's National Medical Products...

2026-06-26 10:08 7969

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias

EPLive 2026 included 1,600 of the world's top cardiac electrophysiology experts AUSTIN, Texas, June 26, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its eighth international symposium on complex arrhythmias on May 28-29, 2026. This year's...

2026-06-26 02:55 6688

Haier Biomedical Debuts Innovative Automated Low-Carbon Cold Storage Products at Two Major Global Industry Trade Fairs

From Europe Biobank Week 2026 in Prague to Interphex Week Tokyo 2026, Haier Biomedical continuously strengthens global life sciences market presence through localized innovative products and profound ecosystem partnerships QINGDAO, China, June 25, 2026 /PRNewswire/ -- Haier Biomedical

2026-06-25 17:34 8467

Malaysian Patient Underwent Advanced Heart Procedure at SinoUnited Health

SHANGHAI, June 25, 2026 /PRNewswire/ -- A Malaysian patient has successfully undergone pulse field ablation (PFA) for persistent atrial fibrillation (AF) in Shanghai. The procedure, performed by internationally renowned cardiac electrophysiologist Dr. Feifan Ouyang, has successfully restored the ...

2026-06-25 14:15 7462

ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific

Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies SHANGHAI, June 25, 2026 /PRNewswire/ -- ATLATL Innovation Center ("ATLATL"), a global innovation platform for life science research and development, and Samsung Bioepis C...

2026-06-25 07:30 8306

Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region

ABU DHABI, UAE, June 25, 2026 /PRNewswire/ -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health – Abu Dhabi (DoH) has announced a  collaboration with global pharmaceutical leader MSD (Merck & Co., Inc., Rahway, New...

2026-06-25 03:15 7866

Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease Research

Dataset from more than 7,500 participants expands multiomic analysis in rare disease research by combining metabolomics with genomic and clinical data MORRISVILLE, N.C., June 24, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, dia...

2026-06-24 21:00 5349

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

* IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. * Waters Biosciences' technologies, including BD FACSDiscover™ and BD Rhapsody™ Instruments, will be used with IMU's AI analy...

2026-06-24 20:00 6666

Tarek Samad appointed EVP, Head of Research & Development at Lundbeck

VALBY, Denmark, June 24, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that Tarek Samad has been appointed Executive Vice President and Head of Research & Development (R&D) and will join the Executive Leadership Team (ELT) effective 1 September 2026. Tarek Samad succeeds Johan ...

2026-06-24 18:19 7852
1 ... 12131415161718 ... 383